Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7510436rdf:typepubmed:Citationlld:pubmed
pubmed-article:7510436lifeskim:mentionsumls-concept:C0043393lld:lifeskim
pubmed-article:7510436lifeskim:mentionsumls-concept:C0376436lld:lifeskim
pubmed-article:7510436lifeskim:mentionsumls-concept:C1514562lld:lifeskim
pubmed-article:7510436lifeskim:mentionsumls-concept:C1883221lld:lifeskim
pubmed-article:7510436lifeskim:mentionsumls-concept:C0872192lld:lifeskim
pubmed-article:7510436lifeskim:mentionsumls-concept:C1883204lld:lifeskim
pubmed-article:7510436lifeskim:mentionsumls-concept:C1283195lld:lifeskim
pubmed-article:7510436lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:7510436lifeskim:mentionsumls-concept:C1880389lld:lifeskim
pubmed-article:7510436lifeskim:mentionsumls-concept:C0292133lld:lifeskim
pubmed-article:7510436pubmed:issue1lld:pubmed
pubmed-article:7510436pubmed:dateCreated1994-4-14lld:pubmed
pubmed-article:7510436pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7510436pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7510436pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7510436pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7510436pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7510436pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7510436pubmed:abstractTextTo identify conserved humoral antigenic determinants within the hepatitis C virus (HCV) envelope protein E2, we expressed a peptide library containing random short fragments of the HCV envelope in yeast. Clones were identified using a monospecific rabbit antibody to a region downstream of the E2 hypervariable region. The clones define the limits of two original antigenic domains: a major one (aa 493-576) and a minor one (aa 535-606). The major antigenic domain maps in a region that displays a high degree of homology within a (HCV) subtype (92-97.6% identity). Yeast-encoded determinants were characterized by Western blot analysis, N-glycosidase F digestion, and using a panel of synthetic peptides. The data suggest that the major antigenic domain contains at least two determinants, one of them mimicked by an 18-mer peptide (aa 514-531). ELISA and competitive inhibition assays demonstrated that: (1) the determinants appear subtype 1a-specific, (2) seroprevalence of antibody to the determinants is rather low (20.6%), and (3) donors show a heterologous response to the different determinants. Antibody response to the E2 determinants was studied in HCV-infected chimpanzees and post-transfusion-associated NANB hepatitis cases. The antibody response was found during chronic infection and may not be effective for virus clearance.lld:pubmed
pubmed-article:7510436pubmed:languageenglld:pubmed
pubmed-article:7510436pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7510436pubmed:citationSubsetIMlld:pubmed
pubmed-article:7510436pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7510436pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7510436pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7510436pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7510436pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7510436pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7510436pubmed:statusMEDLINElld:pubmed
pubmed-article:7510436pubmed:monthAprlld:pubmed
pubmed-article:7510436pubmed:issn0042-6822lld:pubmed
pubmed-article:7510436pubmed:authorpubmed-author:PrinceA MAMlld:pubmed
pubmed-article:7510436pubmed:authorpubmed-author:TiollaisPPlld:pubmed
pubmed-article:7510436pubmed:authorpubmed-author:InchauspeGGlld:pubmed
pubmed-article:7510436pubmed:authorpubmed-author:MadaulePPlld:pubmed
pubmed-article:7510436pubmed:authorpubmed-author:BenichouSSlld:pubmed
pubmed-article:7510436pubmed:authorpubmed-author:MimsM HMHlld:pubmed
pubmed-article:7510436pubmed:issnTypePrintlld:pubmed
pubmed-article:7510436pubmed:volume200lld:pubmed
pubmed-article:7510436pubmed:ownerNLMlld:pubmed
pubmed-article:7510436pubmed:authorsCompleteYlld:pubmed
pubmed-article:7510436pubmed:pagination246-55lld:pubmed
pubmed-article:7510436pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7510436pubmed:meshHeadingpubmed-meshheading:7510436-...lld:pubmed
pubmed-article:7510436pubmed:meshHeadingpubmed-meshheading:7510436-...lld:pubmed
pubmed-article:7510436pubmed:meshHeadingpubmed-meshheading:7510436-...lld:pubmed
pubmed-article:7510436pubmed:meshHeadingpubmed-meshheading:7510436-...lld:pubmed
pubmed-article:7510436pubmed:meshHeadingpubmed-meshheading:7510436-...lld:pubmed
pubmed-article:7510436pubmed:meshHeadingpubmed-meshheading:7510436-...lld:pubmed
pubmed-article:7510436pubmed:meshHeadingpubmed-meshheading:7510436-...lld:pubmed
pubmed-article:7510436pubmed:meshHeadingpubmed-meshheading:7510436-...lld:pubmed
pubmed-article:7510436pubmed:meshHeadingpubmed-meshheading:7510436-...lld:pubmed
pubmed-article:7510436pubmed:meshHeadingpubmed-meshheading:7510436-...lld:pubmed
pubmed-article:7510436pubmed:meshHeadingpubmed-meshheading:7510436-...lld:pubmed
pubmed-article:7510436pubmed:meshHeadingpubmed-meshheading:7510436-...lld:pubmed
pubmed-article:7510436pubmed:meshHeadingpubmed-meshheading:7510436-...lld:pubmed
pubmed-article:7510436pubmed:meshHeadingpubmed-meshheading:7510436-...lld:pubmed
pubmed-article:7510436pubmed:meshHeadingpubmed-meshheading:7510436-...lld:pubmed
pubmed-article:7510436pubmed:meshHeadingpubmed-meshheading:7510436-...lld:pubmed
pubmed-article:7510436pubmed:meshHeadingpubmed-meshheading:7510436-...lld:pubmed
pubmed-article:7510436pubmed:meshHeadingpubmed-meshheading:7510436-...lld:pubmed
pubmed-article:7510436pubmed:meshHeadingpubmed-meshheading:7510436-...lld:pubmed
pubmed-article:7510436pubmed:meshHeadingpubmed-meshheading:7510436-...lld:pubmed
pubmed-article:7510436pubmed:year1994lld:pubmed
pubmed-article:7510436pubmed:articleTitleCharacterization and mapping of a B-cell immunogenic domain in hepatitis C virus E2 glycoprotein using a yeast peptide library.lld:pubmed
pubmed-article:7510436pubmed:affiliationLaboratory of Virology and Parasitology, Lindsley F. Kimball Research Institute of the New York Blood Center, New York 10021.lld:pubmed
pubmed-article:7510436pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7510436pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7510436lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7510436lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7510436lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7510436lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7510436lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7510436lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7510436lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7510436lld:pubmed